BUILD-IN PAGE COMPOSER

MAXIS Global Benefits Network (MAXIS GBN) in April 2022 announced the appointment of Federico Morosi as Chief Technical & Financial Officer, effective on May 2, 2022. Based in Paris, Federico oversees MAXIS GBN’s Finance, Legal, Portfolio Management and Reinsurance & Reporting teams. A member of MAXIS GBN’s Executive Committee, he reports to CEO Mattieu Rouot. Jérôme Picon, Head of Finance & Operations, will be taking on new responsibilities within

TRAVEL

BEAUTY

HIPSTER

Latest Posts

In a recent report published by the Organisation for Economic Co-operation and Development (OECD) on September 20, 2023, the global economic landscape is analyzed, shedding light on the current economic dynamics and projecting the trends for the years 2023 and 2024. The report, which can be accessed here, presents a detailed analysis of the global economic scenario, emphasizing the challenges of confronting inflation and sustaining growth. Global Economic Outlook

In a world where financial boundaries are constantly blurring, understanding the nuances of global capital allocation has never been more critical. The recent NBER research report by Sergio Florez-Orrego, Matteo Maggiori, Jesse Schreger, Ziwen Sun, and Serdil Tinda sheds light on this intricate landscape, offering a road map for future research and policy implications. Let’s delve into the key takeaways from this comprehensive study. The Surge in Cross-Border Investments

Seasonal allergies, a common adversary for many, have far-reaching implications that extend beyond sneezes and itchy eyes. A groundbreaking study titled “Invisible Killer: Seasonal Allergies and Accidents” by Mika Akesaka and Hitoshi Shigeoka delves deep into the unseen repercussions of pollen exposure, unveiling a peril that is more significant than previously perceived. The Underestimated Impact of Pollen Traditionally, the societal cost of pollen exposure has been measured in terms

Antimicrobial resistance (AMR) poses a significant global threat, driven primarily by the misuse of antibiotics. This issue is explored in-depth in an OECD report, which reveals critical insights and potential consequences of unchecked AMR. Key Points: Global Antibiotic Consumption: Over the past two decades, the use of antibiotics in humans has moderately increased in OECD and EU/EEA countries but significantly surged in non-OECD G20 nations. Notably, the consumption of
SHARE

Sample Home 1